Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvingtrans Regulatory News (AVG)

Share Price Information for Avingtrans (AVG)

Share Price is delayed by 15 minutes
Get Live Data
625.00    -27.00 (-4.14%)
Bid:
620.00
Ask:
630.00
Spread: 10.00 (1.613%)
Market Cap: £210.14m
AVG Live PriceLast checked at - London Stock Exchange

Intraday Avingtrans Share Chart

Investment & Trading Update

7 Jun 2007 10:59

For immediate release: 7 June 2007

Avingtrans Plc ("Avingtrans" or the "Group")

Investment in Vehicle Occupancy Limited

Avingtrans plc, the designer, manufacturer and supplier of critical components and associated services to the medical, industrial and global aerospace sectors, in pleased to announce an investment in Vehicle Occupancy Limited ("VOL").

Avingtrans is now the beneficial owner of a 7% interest in VOL resulting from its investment of ‚£200,000. VOL has developed and patented a new system designed to observe and record human occupancy in cars, vans and lorries in both moving and static situations. VOL has awarded Avingtrans with a five year supply and management agreement for poles, housings, assembly and installation.

The system was developed by Dr John Tyrer and his team at Loughborough University and been tested extensively. In its final form the new `dtect camera' is planned to become a major management tool in traffic control worldwide. The system will make it easier to enforce priority lanes for car sharing initiatives and for differential tolling on roads, bridges, tunnels and car parks.

Ken Baker of Avingtrans Plc has been appointed as Chairman of VOL with immediate effect.

Ken Baker commented,

"The use of vehicle occupancy detection systems has been widely acknowledged as a major instrument in the future of worldwide traffic management. VOL is at the forefront of this technology and we are delighted to have acquired a 7% interest and a long term exclusive supply agreement at this stage of its development.

VOL has plans for a series of tests and demonstrations for The Highways Agency and interested City Councils over the next two months. We look forward to reporting the progression of their business."

Aerospace Division - Trading Update

The Company is further pleased to announce that its newly established aerospace component manufacturing facility in Chengdu, China, operating as Sigma, has received all the necessary accreditation for the supply of its components to Europe and the United States. A number of orders and significant supply enquiries for both these regions are currently being processed.

Avingtrans - Directorate Update

Ken Baker is to postpone his planned retirement as Chairman. He will continue to work with the Avingtrans board and senior management in developing VOL and other exciting opportunities around the Group.

Group Trading & Notice of Results

Following the trading update announced on 2 May 2007, sales for the year ended 31 May 2007 are expected to be in line with management's expectations. Trading in the current financial year is in line with management's expectations.

Avingtrans expects to publish preliminary results for the year ended 31 May 2007 on 13 September 2007.

Enquiries:Avingtrans plcKen Baker, Chairman

Steve Lawrence, Managing Director

Tel. 01159 499 020Hansard GroupBen SimonsTel. 020 7245 1100KBC Peel HuntJulian Blunt / David AndersonTel. 020 7418 8900

AVINGTRANS PLC
Date   Source Headline
19th May 202610:20 amRNSHolding(s) in Company
14th May 202612:26 pmRNSHolding(s) in Company
12th May 20267:00 amRNSAdaptix receives CE Certification
6th May 20264:28 pmRNSHolding(s) in Company
30th Apr 20262:42 pmRNSHolding(s) in Company
30th Apr 20262:41 pmRNSExercise of Options & TVR
24th Apr 20262:54 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSStrong Nuclear Orders for Avingtrans
26th Mar 20267:00 amRNS-RScientific Magnetics Ships 20th Quantum Magnet
4th Mar 20267:00 amRNSHolding(s) in Company
25th Feb 20267:00 amRNSInterim Results
12th Feb 202611:49 amRNSHolding(s) in Company
6th Feb 202610:24 amRNSHolding(s) in Company
27th Jan 20265:42 pmRNSExercise of Options & TVR
21st Jan 20267:00 amRNSTrading Update and Notice of Results
12th Jan 20265:13 pmRNSIssue of Share Options
12th Jan 20267:00 amRNS-RMedical & Industrial Imaging Division Appointment
8th Dec 20252:34 pmRNSNotification of Major Holdings
27th Nov 20251:59 pmRNSResult of AGM - Board Appointment
14th Nov 20258:38 amRNSExercise of Options & PDMR Dealings
10th Nov 20257:00 amRNSAdaptix receives FDA 510(K) clearance
1st Oct 20254:52 pmRNSExercise of Options & Total Voting Rights
1st Oct 20253:32 pmRNSHolding(s) in Company
29th Sep 20257:00 amRNSAppointment of Medical Division CEO
24th Sep 20257:00 amRNSPreliminary results for the year ended 31 May 2025
11th Sep 20258:00 amRNSHolding(s) in Company
2nd Sep 20257:00 amRNSHayward Tyler Secures $16m Nuclear Contracts
28th Aug 20257:00 amRNSBooth Industries secures £8.5m HS2 & TfL contracts
25th Jun 20257:00 amRNSTrading Update and Notice of Results
28th May 20257:00 amRNSTrading Update
26th Feb 20257:00 amRNSInterim Results
13th Feb 20257:00 amRNSBooth Industries secures £4.5m Contract
16th Jan 20257:00 amRNSTrading Update & Notice of Results
21st Nov 20244:09 pmRNSResult of AGM
24th Oct 20249:07 amRNSHolding(s) in Company
25th Sep 20247:00 amRNSPreliminary results for the year ended 31 May 2024
3rd Jul 20247:00 amRNSPDMR Dealings
19th Jun 20247:00 amRNSTrading Update and Notice of Results
26th Mar 202411:15 amRNSPDMR Dealings
21st Mar 20245:15 pmRNSExercise of Options, PDMR Dealings & TVR
20th Mar 20243:39 pmRNSHolding(s) in Company
4th Mar 20246:10 pmRNSPDMR Dealings
28th Feb 20247:00 amRNSInterim Results
18th Jan 20247:00 amRNSTrading Update and Notice of Results
15th Dec 20233:00 pmRNSExercise of Options & TVR
4th Dec 20237:00 amRNSMagnetica Limited appoints US distributor
22nd Nov 20237:00 amRNSEmployee & PDMR Share Incentive Awards
16th Nov 20232:20 pmRNSResult of AGM
13th Nov 20237:00 amRNSHayward Tyler Contract Win
11th Oct 20237:00 amRNSContract Wins

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.